p-chloroamphetamine induces c-fos in rat brain: A study of serotonin2A/2C receptor function

Neuroscience

Volumn 72, Issue 1, 1996, Pages 129-139

  Moorman, J M ^a   Leslie, R A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

DOI; Fos immunocytochemistry; p chloroamphetamine; Serotonin receptors

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; CHLORAMPHETAMINE; ONCOPROTEIN; RITANSERIN; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT;

AMPHETAMINES; ANIMALS; BRAIN; BRAIN CHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; P-CHLOROAMPHETAMINE; PRESYNAPTIC TERMINALS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN AGENTS; SEROTONIN AGONISTS;

EID: 0029670493     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00553-6     Document Type: Article

References (49)

1. Adell A., Sarna G. S., Hutson P. H. and Curzon G. (1989) An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br. J. Pharmac. 97, 206-212.
2. 1C receptors in rat brain. J. Pharmac. exp. Ther. 255, 843-857.
3. Axt K. J. and Molliver M. E. (1991) Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9, 302-313.
4. Azmitia E. C. and Segal M. (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. comp. Neurol. 179, 641-668.
5. Bjorklund A. and Lindvall O. (1984) Dopamine-containing systems in the CNS. In Handbook of Chemical Neuroanatomy, Part 1 (eds Bjorklund A. and Hokfelt T.), pp. 55-122. Elsevier Science, Amsterdam.
6. 1 receptor agonists and p-chloroamphetamine. Synapse 5, 120-133.
7. 2 receptors and serotonergic axons in rat neocortex. Brain Res. 453, 315-328.
8. Calloway C. W., Wing L. and Geyer M. A. (1990) Serotonin release contributes to the stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J. Pharmac. exp. Ther. 254, 456-464.
9. Calloway C. W., Johnson M. P., Gold L. H., Nichols D. E. and Geyer M. A. (1991) Amphetamine derivatives produce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacology 104, 293-301.
10. 1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine. Neuropsychopharmacology 7, 113-127.
11. Dragunow M., Logan B. and Laverty R. (1991) 3,4-Methylendioxymethamphetamine induced Fos-like proteins in rat basal ganglia: reversal with MK801. Eur. J. Pharmac. (Molec. Pharmac.) 206, 255-258.
12. Fuller R. W. and Snoddy H. D. (1974) Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole metabolism in rats. Neuropharmacohgy 13, 85.
13. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35, 2505-2511.
14. 2 binding characteristics of 1(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J. med. Chem. 29, 194-199.
15. Grahame-Smith D. G. (1971) Studies in vivo on the relationship between brain tryptophan, brain synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18, 1053-1066.
16. 2 receptor agonists. Eur. J. Pharmac. 264, 325-330.
17. Halasy K., Miettinen R., Szabat E. and Freund T. F. (1992) GABAergic interneurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus. Eur. J. Neurosci. 4, 144-154.
18. Harvey J. A., McMaster S. E. and Yunger L. M. (1975) p-Chloroamphetamine: selective neurotoxic action in brain. Science 187, 841-843.
19. Hensler J. G., Ferry R. C., Labow D. M., Kovochichi G. B. and Frazer A. (1994) Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse 17, 1-15.
20. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. A. (1994) VII International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmac. Rev. 46, 158-203.
21. 2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits. Eur. J. Pharmac. 238, 291-296.
22. Jacobs B. L. and Azmitia E. C. (1992) Structure and function of the brain serotonin system. Physiol. Rev. 72, 165-229.
23. 2/1C receptor activation causes a localised expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres. Neuroscience 53, 457-463.
24. Li B.-H. and Rowland N. E. (1993) Dexfenfluramine induced Fos-like immunoreactivity in discrete brain regions in rats. Brain Res. Bull. 31, 43-48.
25. 2 receptors. Psychopharmacology, Berlin 88, 525-526.
26. Mamounas L. A. and Molliver M. E. (1988) Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA). Expl Neurol. 102, 23-36.
27. Mamounas L. A., Mullen C. A., O'Hearn E. and Molliver M. E. (1991) Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives. J. comp. Neurol. 314, 558-586.
28. McQuade R. and Sharp T. (1995) Release of cerebral 5-hydroxytryptamine evoked by electrical stimulation of the dorsal and median raphe nucleus: effect of a neurotoxic amphetamine. Neuroscience 68, 1079-1088.
29. Molliver M. E., Mamounas L. A. and Wilson M. A. (1989) Effects of neurotoxic amphetamines on serotonergic neurones: immunocytochemical studies. In Pharmacology and Toxicology of Amphetamine and Related Designer Drugs (eds Asghar K. and De Sousa E.), NIDA Research Monograph Washington, D.C. Vol. 94, pp. 270-304.
30. Molliver M. E., Berger U. V., Mamounas L. A., Molliver D. C., O'Hearn E. and Wilson M. A. (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N. Y. Acad. Sci. 60, 640-664.
31. Molliver D. C. and Molliver M. E. (1990) Anatomic evidence for a neurotoxic effect of fenfluramine upon serotonergic projections in the rat. Brain Res. 511, 165-168.
32. 3H]-serotonin from rat brain synaptosomes. J. med. Chem. 25, 530-534.
33. O'Hearn E. and Molliver M. E. (1984) Organisation of raphe-cortical projections in the rat; a quantitative retrograde study. Brain Res. Bull. 13, 709-726.
34. Paul M. L., Graybiel A. M., David J.-C. and Robertson H. A. (1992) D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12, 3729-3742.
35. Paulus M. and Geyer M. A. (1992) The effects of MDMA and other methylendioxy-substituted phenylalkylamines on the structures of rat locomotor activity. Neuropsychopharmacology 7, 15-31.
36. Peroutka S. J. (1987) Incidence of recreational use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") on an undergraduate campus. New Engl. J. Med. 24, 1542-1543.
37. 1C receptors in the behavioural effects of the 5-HT agonist 1(2,5-dimethoxy-4-iodophenylaminopropane)-2 (DOI). Neurosci. Lett. 115, 74-80.
38. Richard D., Rivest S. and Rivier C. (1992) The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res. 594, 131-137.
39. Sanders-Bush E., Bushing J. A. and Seiden L. S. (1972) Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in brain. Eur. J. Pharmac. 20, 385-388.
40. Schmidt C. J. and Kehne J. H. (1990) Neurotoxicity of MDMA: neurochemical effects. Ann. N. Y. Acad. Sci. 600, 655-681.
41. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylendioxymethamphetamine. J. Neurochem. 62, 382-389.
42. Series H. G., Cowen P. J. and Sharp T. (1994) p-Chloroamphetamine (PCA), 3,4-methylendioxymethamphetamine (MDMA) and D-fenfluramine pretreatment attenuates D-fenfluramine-evoked release of 5-HT in vivo. Psychopharmacology 116, 508-514.
43. Series H. G. and Molliver M. E. (1994) Immunocytochemical evidence for serotonergic neurotoxicity of N-ethylmethylenedioxyamphetamine (MDE). Expl Neurol. 128, 50-58.
44. Sharp T. Zetterström T., Christmanson L. and Ungerstedt U. (1986) p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci. Lett. 72, 320-324.
45. Torres G. and Rivier C. (1993) Regional effect of NMDA receptor antagonists on the induction of striatal c-fos by fenfluramine. Molec. cell Neurosci. 4, 231-236.
46. Trulson M. E. and Jacobs B. L. (1976) Behavioural evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur. J. Pharmac. 36, 149-154.
47. Umino A., Nishikawa T. and Takahashi K. (1995) Methamphetamine-induced nuclear c-fos in rat brain regions. Neurochem. Int. 26, 85-90.
48. Wagner J. and Peroutka S. J. (1990) Neurochemistry and neurotoxicity of substituted amphetamines. Neuropsychopharmacology 3, 219-220.
49. Yamamoto B. K. and Spanos L. J. (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake behaving rat. Eur. J. Pharmac. 148, 195-203.